Shuangquan Qin

Shuangquan Qin

Auto-generated profile, based on publicly available information

Shuangquan Qin

Emergency Department, First People’s Hospital of Changde City, Hunan Province, Jilin City, Jilin Province, China

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2026 in Investigación Clínica
Verified
Journal Article
Open access
HLHongfeng Liu
Hongfeng Liu
Lihui LuoLihui Luo
Lihui Luo
AMAmol Muthal
Amol Muthal
SQShuangquan Qin
Shuangquan Qin
Biliary acute pancreatitis (BAP) has no specific pharmacotherapy beyond supportive care and stone removal. This study evaluated the protective ef-ficacy and putative molecular mechanisms of apigenin, a dietary flavonoid with an-tioxidant and anti-inflammatory properties, in an L -arginine-induced model of BAP in rats. Adult male Wistar rats (n=8/group) received oral vehicle (DMSO), meth-ylprednisolone (30 mg/kg), or apigenin (5, 10, or 20 mg/kg) for seven days, after BAP was induced (except in the normal group) by two intraperitoneal injections of 8% L -arginine (2.5 g/kg, 1 h apart). At the end of the study, various biomarkers were assessed. L -arginine produced pronounced pancreatic edema (p<0.001) and increased pancreatic weight; elevated serum amylase, lipase, and C-reactive protein; and concomitant hypocalcemia. It also increased pancreatic malondialdehyde and nitric oxide, depleted reduced glutathione and antioxidant enzyme activities (includ-ing catalase and superoxide dismutase), increased myeloperoxidase, and increased tumor necrosis factor-α, interleukin (IL)-1β, and IL -6. These changes were accompa-nied by severe inflammatory infiltration, edema, and necrosis, and by marked upreg-ulation of insulin-like growth factor-binding protein (IGFBP)-4, G protein-coupled bile acid receptor (GPBAR)-1, and G protein-coupled receptor (GPR)-39 mRNA (all p<0.001 vs. normal). Apigenin (10 and 20 mg/kg) dose-dependently reversed these biochemical and histological abnormalities and downregulated IGFBP4, GPR39, and GPBAR1 mRNA expression, with effects comparable to those of methylpred-nisolone. The expression of IGFBP4, GPBAR1, and GPR39 was positively correlated with amylase, lipase, and edema severity. In conclusion, these findings support api-genin as a multi-target adjunct candidate for BAP, acting by attenuating oxidonitro-sative stress, neutrophil-associated injury (IGFBP4 and GPBAR1), inflammatory cytokines, and disease-associated transcriptional programs (GPR39).